Corrigendum to “Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus” [Heliyon 9(4) (April 2023) e15032] (Heliyon (2023) 9(4), (S2405844023022399), (10.1016/j.heliyon.2023.e15032))

Nancy E. Hernandez; Wojciech Jankowski; Rahel Frick; Simon P. Kelow; Joseph H. Lubin; Vijaya Simhadri; Jared Adolf-Bryfogle; Sagar D. Khare; Roland L. Dunbrack; Jeffrey J. Gray; Zuben E. Sauna

doi:10.1016/j.heliyon.2023.e17901

Corrigendum to “Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus” [Heliyon 9(4) (April 2023) e15032] (Heliyon (2023) 9(4), (S2405844023022399), (10.1016/j.heliyon.2023.e15032))

Nancy E. Hernandez, Wojciech Jankowski, Rahel Frick, Simon P. Kelow, Joseph H. Lubin, Vijaya Simhadri, Jared Adolf-Bryfogle, Sagar D. Khare, Roland L. Dunbrack, Jeffrey J. Gray, Zuben E. Sauna

Whiting School of Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the original published version of this article, some supplementary data was missing. This has now been provided by the author. The authors apologize for the errors. Both the HTML and PDF versions of the article have been updated to correct the errors.

Original language	English (US)
Article number	e17901
Journal	Heliyon
Volume	9
Issue number	8
DOIs	https://doi.org/10.1016/j.heliyon.2023.e17901
State	Published - Aug 2023

ASJC Scopus subject areas

General

Access to Document

10.1016/j.heliyon.2023.e17901

Fingerprint

Dive into the research topics of 'Corrigendum to “Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus” [Heliyon 9(4) (April 2023) e15032] (Heliyon (2023) 9(4), (S2405844023022399), (10.1016/j.heliyon.2023.e15032))'. Together they form a unique fingerprint.

Cite this

Hernandez, N. E., Jankowski, W., Frick, R., Kelow, S. P., Lubin, J. H., Simhadri, V., Adolf-Bryfogle, J., Khare, S. D., Dunbrack, R. L., Gray, J. J., & Sauna, Z. E. (2023). Corrigendum to “Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus” [Heliyon 9(4) (April 2023) e15032] (Heliyon (2023) 9(4), (S2405844023022399), (10.1016/j.heliyon.2023.e15032)). Heliyon, 9(8), Article e17901. https://doi.org/10.1016/j.heliyon.2023.e17901

Corrigendum to “Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus” [Heliyon 9(4) (April 2023) e15032] (Heliyon (2023) 9(4), (S2405844023022399), (10.1016/j.heliyon.2023.e15032)). / Hernandez, Nancy E.; Jankowski, Wojciech; Frick, Rahel et al.
In: Heliyon, Vol. 9, No. 8, e17901, 08.2023.

Research output: Contribution to journal › Comment/debate › peer-review

Hernandez, NE, Jankowski, W, Frick, R, Kelow, SP, Lubin, JH, Simhadri, V, Adolf-Bryfogle, J, Khare, SD, Dunbrack, RL, Gray, JJ & Sauna, ZE 2023, 'Corrigendum to “Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus” [Heliyon 9(4) (April 2023) e15032] (Heliyon (2023) 9(4), (S2405844023022399), (10.1016/j.heliyon.2023.e15032))', Heliyon, vol. 9, no. 8, e17901. https://doi.org/10.1016/j.heliyon.2023.e17901

Hernandez NE, Jankowski W, Frick R, Kelow SP, Lubin JH, Simhadri V et al. Corrigendum to “Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus” [Heliyon 9(4) (April 2023) e15032] (Heliyon (2023) 9(4), (S2405844023022399), (10.1016/j.heliyon.2023.e15032)). Heliyon. 2023 Aug;9(8):e17901. doi: 10.1016/j.heliyon.2023.e17901

Hernandez, Nancy E. ; Jankowski, Wojciech ; Frick, Rahel et al. / Corrigendum to “Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus” [Heliyon 9(4) (April 2023) e15032] (Heliyon (2023) 9(4), (S2405844023022399), (10.1016/j.heliyon.2023.e15032)). In: Heliyon. 2023 ; Vol. 9, No. 8.

@article{cb47a0c2f28242b69ba0abe948ce0dae,

title = "Corrigendum to “Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus” [Heliyon 9(4) (April 2023) e15032] (Heliyon (2023) 9(4), (S2405844023022399), (10.1016/j.heliyon.2023.e15032))",

abstract = "In the original published version of this article, some supplementary data was missing. This has now been provided by the author. The authors apologize for the errors. Both the HTML and PDF versions of the article have been updated to correct the errors.",

author = "Hernandez, {Nancy E.} and Wojciech Jankowski and Rahel Frick and Kelow, {Simon P.} and Lubin, {Joseph H.} and Vijaya Simhadri and Jared Adolf-Bryfogle and Khare, {Sagar D.} and Dunbrack, {Roland L.} and Gray, {Jeffrey J.} and Sauna, {Zuben E.}",

note = "Publisher Copyright: {\textcopyright} 2023 The Author(s)",

year = "2023",

month = aug,

doi = "10.1016/j.heliyon.2023.e17901",

language = "English (US)",

volume = "9",

journal = "Heliyon",

issn = "2405-8440",

publisher = "Elsevier Ltd",

number = "8",

}

TY - JOUR

T1 - Corrigendum to “Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus” [Heliyon 9(4) (April 2023) e15032] (Heliyon (2023) 9(4), (S2405844023022399), (10.1016/j.heliyon.2023.e15032))

AU - Hernandez, Nancy E.

AU - Jankowski, Wojciech

AU - Frick, Rahel

AU - Kelow, Simon P.

AU - Lubin, Joseph H.

AU - Simhadri, Vijaya

AU - Adolf-Bryfogle, Jared

AU - Khare, Sagar D.

AU - Dunbrack, Roland L.

AU - Gray, Jeffrey J.

AU - Sauna, Zuben E.

PY - 2023/8

Y1 - 2023/8

N2 - In the original published version of this article, some supplementary data was missing. This has now been provided by the author. The authors apologize for the errors. Both the HTML and PDF versions of the article have been updated to correct the errors.

AB - In the original published version of this article, some supplementary data was missing. This has now been provided by the author. The authors apologize for the errors. Both the HTML and PDF versions of the article have been updated to correct the errors.

UR - http://www.scopus.com/inward/record.url?scp=85171658819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85171658819&partnerID=8YFLogxK

U2 - 10.1016/j.heliyon.2023.e17901

DO - 10.1016/j.heliyon.2023.e17901

M3 - Comment/debate

C2 - 37701412

AN - SCOPUS:85171658819

SN - 2405-8440

VL - 9

JO - Heliyon

JF - Heliyon

IS - 8

M1 - e17901

ER -

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this